We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$2.51B
AUM Growth
+$246M
Cap. Flow
+$146M
Cap. Flow %
5.81%
Top 10 Hldgs %
61.67%
Holding
3,166
New
364
Increased
1,456
Reduced
496
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 7.52%
2 Consumer Discretionary 5.28%
3 Financials 4.29%
4 Healthcare 3.52%
5 Communication Services 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVS
2651
DELISTED
Clovis Oncology, Inc.
CLVS
$2K ﹤0.01%
263
+49
+23% +$287
AERI
2652
DELISTED
Aerie Pharmaceuticals
AERI
$2K ﹤0.01%
+155
New +$2.66K
MANT
2653
DELISTED
Mantech International Corp
MANT
$2K ﹤0.01%
26
EPZM
2654
DELISTED
Epizyme, Inc
EPZM
$2K ﹤0.01%
234
+233
+23,300% +$1.96K
GSS
2655
DELISTED
Golden Star Resources Ltd.
GSS
$2K ﹤0.01%
585
+261
+81% +$873
CVA
2656
DELISTED
Covanta Holding Corporation
CVA
$2K ﹤0.01%
121
CORE
2657
DELISTED
Core Mark Holding Co., Inc.
CORE
$2K ﹤0.01%
54
-25
-32% -$1.1K
VSTO
2658
DELISTED
Vista Outdoor Inc.
VSTO
$2K ﹤0.01%
53
BDSI
2659
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2K ﹤0.01%
+655
New +$2.31K
CADE
2660
DELISTED
Cadence Bancorporation
CADE
$2K ﹤0.01%
98
ABR icon
2661
Arbor Realty Trust
ABR
$977M
$1K ﹤0.01%
+74
New +$1.3K
ACTG icon
2662
Acacia Research
ACTG
$437M
$1K ﹤0.01%
+120
New +$714
ADAP
2663
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
224
-720
-76% -$3.5K
AGX icon
2664
Argan
AGX
$6.9B
$1K ﹤0.01%
24
AIEQ icon
2665
Amplify AI Powered Equity ETF
AIEQ
$119M
$1K ﹤0.01%
+20
New +$777
AIV
2666
Aimco
AIV
$377M
$1K ﹤0.01%
77
ALGT icon
2667
Allegiant Air
ALGT
$2.57B
$1K ﹤0.01%
+5
New +$1.12K
ALLO icon
2668
Allogene Therapeutics
ALLO
$625M
$1K ﹤0.01%
30
+3
+11% +$86
ALLT icon
2669
Allot
ALLT
$362M
$1K ﹤0.01%
+46
New +$847
ALXO icon
2670
ALX Oncology
ALXO
$262M
$1K ﹤0.01%
+14
New +$838
AOR icon
2671
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.61B
$1K ﹤0.01%
+16
New +$884
AOUT icon
2672
American Outdoor Brands
AOUT
$158M
$1K ﹤0.01%
+19
New +$560
ARCT icon
2673
Arcturus Therapeutics
ARCT
$165M
$1K ﹤0.01%
+32
New +$1.08K
ARR
2674
Armour Residential REIT
ARR
$2.32B
$1K ﹤0.01%
24
+9
+60% +$540
ASIX icon
2675
AdvanSix
ASIX
$542M
$1K ﹤0.01%
41
-41
-50% -$1.23K

Similar funds

SignatureFD's Q2 2021 Portfolio in Review

As of Q2 2021, SignatureFD held 3,166 positions worth $2.51B, up 11% from $2.26B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

SignatureFD deployed $146M of net new capital in Q2 2021, opening 364 new positions and adding to 1,456 existing holdings. Its largest new stake was Danimer Scientific, Inc.: 1,202 shares worth $1.2M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, up from 6.9% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $40.5M trimmed.

  • SignatureFD's largest Q2 2021 buy was Danimer Scientific, Inc.: 1,202 shares worth $1.2M.
  • SignatureFD added most to iShares Core S&P US Value ETF in Q2 2021, an estimated $48.7M increase.
  • SignatureFD's biggest Q2 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $40.5M.
  • SignatureFD fully exited WisdomTree US Value Fund in Q2 2021, selling an estimated $269K.
  • SignatureFD's ten largest holdings make up 62% of its $2.51B portfolio in Q2 2021.
  • SignatureFD opened 364 new positions and closed 157 in Q2 2021.
  • SignatureFD's portfolio value rose 11% quarter-over-quarter to $2.51B.

Based on SignatureFD's 13F filing for Q2 2021, filed 26 Jul 2021.